asa glp 1 guidelines A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia GLP-1 Receptor Agonists in Gastrointestinal

Weeks 17-24 (12.5-15mg): Maximum dose territory

In addition, it has been found that inflammation can induce GERD by decreasing the function of the upper laryngeal-esophageal sphincter and pharyngeal-esophageal sphincter receptors (67)

Choline excess can produce trimethylamine-related odor

Reported Adverse Effects Reported adverse effects from online forums cited in a 2025 systematic review (PMC12313605) included: Anxiety and panic attacks Depression and anhedonia Insomnia Heart palpitations Fatigue and weakness Loss of appetite These anecdotal reports cannot be verified as directly caused by BPC-157 versus contamination, incorrect dosing, or concurrent conditions, but they raise concerns that the peptide might paradoxically worsen mental health in some individuals